This study focused on severely obese patients with insulin-treated T2D and noted that there is a relationship between bariatric surgical intervention and protective effect against CKD and observed improvements in overall patients’ renal outcomes, with benefits reaching patients with or without microalbuminuria at baseline. Here, INS is linked to chronic kidney disease.